<DOC>
	<DOCNO>NCT02021123</DOCNO>
	<brief_summary>Because anidulafungin generally well tolerated appear limited interaction drug , potential important agent treatment invasive fungal infection . Although anidulafungin approve treatment invasive candidiasis adult non-neutropenic patient , dose guideline anidulafungin ( morbidly ) obese patient available . Subsequently , pharmacokinetic profile anidulafungin ( well echinocandins ) specific patient population still largely unknown . During endoscopic gastric bypass surgery , patient prone various kind infection , justify prophylactic use anidulafungin specific cohort patient . To build valid pharmacokinetic model , obese patient BMI ≥ 40 undergoing endoscopic gastric bypass surgery receive single dose 100 mg anidulafungin ( besides standard anti-bacterial prophylaxis ) PK-curve drawn . These PK-values compare pharmacokinetics normal-weight group .</brief_summary>
	<brief_title>Anidulafungin Pharmacokinetics Given Single Intravenous Dose Obese Patients ( ADOPT )</brief_title>
	<detailed_description>All obese patient BMI ≥ 40 kg/m2 undergo endoscopic gastric bypass surgery receive prophylactic single dose 100 mg anidulafungin include analysis . A PK curve determine administration anidulafungin t=0.5 , 1 , end infusion , 2 , 4 , 6 , 8 , 10 , 12 , 24 , 48 ( feasible ) 72 hour post infusion ( n=12 sample ) . Blood sample ( 4 mL ) PK day take obtain least 2.0 mL plasma .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>1 . Patient BMI ≥40 kg/m2 undergoing endoscopic gastric bypass surgery . 2 . Subject least 18 year age day screen . 3 . If subject female : neither pregnant , able become pregnant nursing infant . 4 . Subject legal representative able willing sign Informed Consent screen evaluation . 1 . Documented history sensitivity medicinal product excipients similar find echinocandin preparation . 2 . History , current abuse drug , alcohol solvent . 3 . Inability understand nature trial procedure require .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Anidulafungin</keyword>
	<keyword>Gastric bypass</keyword>
	<keyword>Morbidly obese</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Yeast infection</keyword>
</DOC>